← Leaderboards
G. Yancey Gillespie
University Of Alabama At Birmingham
$5,456,344
Attributed
$9,323,303
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–21$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$18,246,719 · 8
By mechanism
P50$8,923,416 · 1
U01$3,737,154 · 1
P20$2,300,000 · 2
R01$1,604,566 · 1
P01$1,297,434 · 2
P30$384,149 · 1
Top collaborators
- Anita Borton Hjelmeland6 shared
- Christopher D Willey6 shared
- Jake Yue Chen5 shared
- Xiangqin Cui5 shared
- Raj K. Singh5 shared
- James M Markert3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- James M Markert$5,310,460
- Christopher D Willey$2,398,828
- Xiangqin Cui$800,390
- Jake Yue Chen$4,305,293
- Richard J. Whitley$15,110,969
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaClinical TrialsResearch PersonnelBrain NeoplasmsProgramsMalignant Neoplasm Of BrainMalignant GliomaTranslatingLaboratoriesMalignant NeoplasmsMolecularFundingTumor BiologyDrug DevelopmentBiologyResearch Project GrantsScientistTranslational ResearchGrantPhase I Clinical TrialsRecurrenceTumorBehaviorDoctor Of Philosophy
Grant awards (39)
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$790,576
U01 · FY2021 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$333,751
U01 · FY2021 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$827,700
U01 · FY2020 · CA
Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.$297,715
U01 · FY2020 · CA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$746,835
U01 · FY2019 · CA
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.$478,440
R01 · FY2019 · CA
04 Neuro-Oncology Program$116,289
P30 · FY2019 · CA · contact PI
04 Neuro-Oncology Program$8,695
P30 · FY2019 · CA · contact PI
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress$740,577
U01 · FY2018 · CA
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.$559,312
R01 · FY2018 · CA
04 Neuro-Oncology Program$96,888
P30 · FY2018 · CA · contact PI
04 Neuro-Oncology Program$8,649
P30 · FY2018 · CA · contact PI
04 Neuro-Oncology Program$3,965
P30 · FY2018 · CA · contact PI
04 Neuro-Oncology Program$2,264
P30 · FY2018 · CA · contact PI
04 Neuro-Oncology Program$1,978
P30 · FY2018 · CA · contact PI
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.$566,814
R01 · FY2017 · CA
04 Neuro-Oncology Program$108,080
P30 · FY2017 · CA · contact PI
04 Neuro-Oncology Program$28,647
P30 · FY2016 · CA · contact PI
04 Neuro-Oncology Program$8,694
P30 · FY2016 · CA · contact PI
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS$700,000
P20 · FY2013 · CA · contact PI
Experimental Glioma Animal Models Core$163,735
P01 · FY2013 · CA · contact PI
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS$700,000
P20 · FY2012 · CA · contact PI
Experimental Glioma Animal Models Core$175,199
P01 · FY2012 · CA · contact PI
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS$900,000
P20 · FY2011 · CA · contact PI
Experimental Glioma Animal Models Core$175,417
P01 · FY2011 · CA · contact PI
Experimental Glioma Animal Models Core$180,806
P01 · FY2010 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$246,417
P50 · FY2009 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$233,144
P50 · FY2009 · CA · contact PI
Experimental Glioma Animal Models Core$180,240
P01 · FY2009 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$1,073,000
P50 · FY2007 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$129,320
P50 · FY2007 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$2,331,436
P50 · FY2006 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$124,791
P50 · FY2006 · CA · contact PI
Molecular Therapeutics for Anaplastic Gliomas$2,343,947
P50 · FY2005 · CA
Molecular Therapeutics for Anaplastic Gliomas$103,623
P50 · FY2005 · CA
Molecular Therapeutics for Anaplastic Gliomas$2,337,738
P50 · FY2004 · CA
Virus adjunctive therapies for pancreatic cancer$0
P20 · FY2003 · CA
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY$206,819
P01 · FY2001 · CA
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY$215,218
P01 · FY2000 · CA